LUNG Q1 2024 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$19M+29.7% YoY

Gross Profit

$14M74.1% margin

Operating Income

-$15M-77.1% margin

Net Income

-$14M-72.9% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-2.2%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$165M

Total Liabilities

$54M

Stockholders' Equity

$110M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$15M	+29.7%
Gross Profit	$14M	$11M	+32.0%
Operating Income	-$15M	-$16M	+11.4%
Net Income	-$14M	-$16M	+13.3%

Geographic Segments

UNITED STATES

$13M68%

EMEA

$5M27%

Asia Pacific

$698,0004%

Other International Geographical Areas

$171,0001%